Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Nicholas

Showing results (91-100 of 94) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 94 results.
Plos One|June 14, 2013
A modified RNA-Seq approach for whole genome sequencing of RNA viruses from faecal and blood samplesElizabeth M Batty, T H Nicholas Wong, Amy Trebes, et al.
Journal of the American College of Cardiology|October 7, 2004
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trialPatrick W Serruys, John A Ormiston, Georgios Sianos, et al.
Mabs|November 25, 2010
A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptorStuart L Emanuel, Linda J Engle, Ginger Chao, et al.
The New England Journal of Medicine|January 31, 2019
Oral versus Intravenous Antibiotics for Bone and Joint InfectionHo-Kwong Li, Ines Rombach, Rhea Zambellas, et al.
Pageof 10

Showing results (91-100 of 94) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 94 results.
Plos One|June 14, 2013
A modified RNA-Seq approach for whole genome sequencing of RNA viruses from faecal and blood samplesElizabeth M Batty, T H Nicholas Wong, Amy Trebes, et al.
Journal of the American College of Cardiology|October 7, 2004
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trialPatrick W Serruys, John A Ormiston, Georgios Sianos, et al.
Mabs|November 25, 2010
A fibronectin scaffold approach to bispecific inhibitors of epidermal growth factor receptor and insulin-like growth factor-I receptorStuart L Emanuel, Linda J Engle, Ginger Chao, et al.
The New England Journal of Medicine|January 31, 2019
Oral versus Intravenous Antibiotics for Bone and Joint InfectionHo-Kwong Li, Ines Rombach, Rhea Zambellas, et al.
Pageof 10